Comparison of Treatment Effect of Chinese Medicine and Western Medicine on Depression in China and America

NCT ID: NCT01558154

Last Updated: 2012-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-03-31

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of different assessment methods to evaluate the treatment efficacy of Chinese medicine on minor and mild depression.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Significant differences show on the evaluation of treatment efficacy of Chinese medicine on depression in China and America. Choose minor and mild depression patients as trials. One hundred and sixty trials will be included and randomly divided into Chinese medicine group (n=40), acupuncture group (n=40), traditional Chinese medicine psychology group (n=40) and physical treatment group (n=40). Time points of assessment are before treatment, 1 week, 2 weeks, 4weeks, 6 weeks and 12 weeks post treatment.The assessment tools are series of psychological questionnaires. And study the mechanism of treatment efficacy assessment variances by different methods.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chinese herb

Chinese herbs special for depression

Group Type EXPERIMENTAL

Chinese herbs

Intervention Type DRUG

Chinese herbs special for depression

acupuncture

Group Type EXPERIMENTAL

acupuncture

Intervention Type PROCEDURE

six acupuncture point including DU20, EX HN3, EX HN1, PC6,HT7,SP6,special for depression

Psychotherapy

Group Type EXPERIMENTAL

Psychotherapy

Intervention Type OTHER

Thought Imprint Psychotherapy under lower Resistance State

physiotherapy

Group Type EXPERIMENTAL

Transcranial magnetic stimulation

Intervention Type DEVICE

Give magnetic stimulation at head

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chinese herbs

Chinese herbs special for depression

Intervention Type DRUG

acupuncture

six acupuncture point including DU20, EX HN3, EX HN1, PC6,HT7,SP6,special for depression

Intervention Type PROCEDURE

Psychotherapy

Thought Imprint Psychotherapy under lower Resistance State

Intervention Type OTHER

Transcranial magnetic stimulation

Give magnetic stimulation at head

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* According with ICD-10 criteria of depression;
* Age 16-70;
* Antidepressant and other Psychiatric drugs have not been had two weeks before the trial, or the drugs above had been used but have cleaning period of two weeks;
* Level of education is higher than junior middle school;
* Course of disease is more than two weeks;
* Volunteer to join and Signed the informed consent

Exclusion Criteria

* Pregnancy or lactation;
* Severe depression or have serious suicidal tendencies
* long distance or other causes who can not adherence to treatment
Minimum Eligible Age

16 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

California Pacific Medical Center Research Institute

OTHER

Sponsor Role collaborator

Massachusetts General Hospital

OTHER

Sponsor Role collaborator

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xue Yan

Psychology Department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Weidong Wang, master

Role: STUDY_CHAIR

Guang'anmen Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Guang'anmen Hospital

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Weidong Wang, Master

Role: CONTACT

86-10-88001261

Xue Yan, Doctor

Role: CONTACT

86-10-88001178

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xue Yan, doctor

Role: primary

86-10-88001178

Xueyu Lv, doctor

Role: backup

86-10-88001178

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011DFA30960

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of WBT for CI With Depression
NCT06968013 RECRUITING NA
Acupuncture for Anxiety and Depression
NCT06994351 NOT_YET_RECRUITING NA